UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025453
Receipt number R000029289
Scientific Title A multi-institutional clinical trial of proton beam therapy for localized intermediate-risk prostate cancer
Date of disclosure of the study information 2017/03/01
Last modified on 2024/01/05 12:13:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multi-institutional clinical trial of proton beam therapy for
localized intermediate-risk prostate cancer

Acronym

A multi-institutional clinical trial of proton beam therapy for
localized intermediate-risk prostate cancer

Scientific Title

A multi-institutional clinical trial of proton beam therapy for
localized intermediate-risk prostate cancer

Scientific Title:Acronym

A multi-institutional clinical trial of proton beam therapy for
localized intermediate-risk prostate cancer

Region

Japan


Condition

Condition

localized intermediate-risk prostate cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and feasibility of proton beam radiation therapy for intermediate-risk prostate cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-year biochemical relapse-free survival rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Proton beam radiation therapy (63 GyE)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male

Key inclusion criteria

Pathology: Adenocarcinoma
No LN/distant metastasis
KPS: 70 or more and estimated 5-year survival
Androgen deprivation therapy: 6-8 months
A written informed consent

Key exclusion criteria

Previous prostate cancer treatment: surgery, HIFU, chemotherapy, and others
Other cancers within 5 years
History of radiation therapy for pelvis
Uncontrolled infection or DM
more than 135 Kg

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hideyuki
Middle name
Last name Sakurai

Organization

University of Tsukuba, Faculty of Medicine

Division name

Radiation Oncology

Zip code

305-8576

Address

1-1-1, Tennodai, Tsukuba, Ibaraki

TEL

0298537100

Email

hsakurai@pmrc.tsukuba.ac.jp


Public contact

Name of contact person

1st name Hitoshi
Middle name
Last name Ishikawa

Organization

University of Tsukuba, Faculty of Medicine

Division name

Proton Medical Research Center

Zip code

305-8576

Address

1-1-1, Tennodai, Tsukuba, Ibaraki

TEL

0298537100

Homepage URL


Email

hishikawa@pmrc.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba

Address

2-1-1 Amakubo Tsukuba Ibaraki Japan

Tel

0298537100

Email

hishikawa@pmrc.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)
相澤病院(長野県)
脳神経疾患研究所附属南東北がん陽子線治療センター(福島県)
静岡県立静岡がんセンター(静岡県)
名古屋市立西部医療センター(愛知県)
福井県立病院(福井県)
メディポリス国際陽子線治療センター(鹿児島県)
津山中央病院(岡山県)
札幌禎心会病院(北海道)
大阪陽子線クリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 12 Month 21 Day

Date of IRB


Anticipated trial start date

2017 Year 12 Month 26 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 28 Day

Last modified on

2024 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name